These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
372 related articles for article (PubMed ID: 30214155)
21. [Pitolisant for the treatment of narcolepsy with or without cataplexy]. Bruhn C Med Monatsschr Pharm; 2016 Aug; 39(8):324-9. PubMed ID: 29984945 [TBL] [Abstract][Full Text] [Related]
22. Update on the treatment of narcolepsy: clinical efficacy of pitolisant. Calik MW Nat Sci Sleep; 2017; 9():127-133. PubMed ID: 28490912 [TBL] [Abstract][Full Text] [Related]
23. An evaluation of sodium oxybate as a treatment option for narcolepsy. Abad VC Expert Opin Pharmacother; 2019 Jul; 20(10):1189-1199. PubMed ID: 31136215 [No Abstract] [Full Text] [Related]
24. Real-world treatment of pediatric narcolepsy with pitolisant: A retrospective, multicenter study. Triller A; Pizza F; Lecendreux M; Lieberich L; Rezaei R; Pech de Laclause A; Vandi S; Plazzi G; Kallweit U Sleep Med; 2023 Mar; 103():62-68. PubMed ID: 36758348 [TBL] [Abstract][Full Text] [Related]
25. Efficacy of pitolisant in patients with high burden of narcolepsy symptoms: pooled analysis of short-term, placebo-controlled studies. Davis CW; Kallweit U; Schwartz JC; Krahn LE; Vaughn B; Thorpy MJ Sleep Med; 2021 May; 81():210-217. PubMed ID: 33721598 [TBL] [Abstract][Full Text] [Related]
26. [Advances in treatment of narcolepsy]. Xu Q; Lou G; Wang T; Zhang L Zhejiang Da Xue Xue Bao Yi Xue Ban; 2020 Aug; 49(4):419-424. PubMed ID: 32985153 [TBL] [Abstract][Full Text] [Related]
27. [Integrated treatment of the symptoms of narcolepsy-cataplexy syndrome with sodium oxybate]. Poza-Aldea JJ Rev Neurol; 2009 Jan 1-15; 48(1):27-31. PubMed ID: 19145563 [TBL] [Abstract][Full Text] [Related]
28. Gamma-hydroxybutyrate (GHB) for narcolepsy in adults: an updated systematic review and meta-analysis. Xu XM; Wei YD; Liu Y; Li ZX Sleep Med; 2019 Dec; 64():62-70. PubMed ID: 31671326 [TBL] [Abstract][Full Text] [Related]
29. Pharmacological management of narcolepsy with and without cataplexy. Kallweit U; Bassetti CL Expert Opin Pharmacother; 2017 Jun; 18(8):809-817. PubMed ID: 28443381 [TBL] [Abstract][Full Text] [Related]
31. Narcolepsy in the older adult: epidemiology, diagnosis and management. Chakravorty SS; Rye DB Drugs Aging; 2003; 20(5):361-76. PubMed ID: 12696996 [TBL] [Abstract][Full Text] [Related]
32. Modafinil : A Review of its Pharmacology and Clinical Efficacy in the Management of Narcolepsy. McClellan KJ; Spencer CM CNS Drugs; 1998 Apr; 9(4):311-24. PubMed ID: 27521015 [TBL] [Abstract][Full Text] [Related]
33. European guideline and expert statements on the management of narcolepsy in adults and children. Bassetti CLA; Kallweit U; Vignatelli L; Plazzi G; Lecendreux M; Baldin E; Dolenc-Groselj L; Jennum P; Khatami R; Manconi M; Mayer G; Partinen M; Pollmächer T; Reading P; Santamaria J; Sonka K; Dauvilliers Y; Lammers GJ Eur J Neurol; 2021 Sep; 28(9):2815-2830. PubMed ID: 34173695 [TBL] [Abstract][Full Text] [Related]
34. Efficacy of Pitolisant on the Treatment of Narcolepsy: A Systematic Review. Fabara SP; Ortiz JF; Anas Sohail A; Hidalgo J; Altamimi A; Tama B; Patel UK Cureus; 2021 Jul; 13(7):e16095. PubMed ID: 34345566 [TBL] [Abstract][Full Text] [Related]
36. Impact of sodium oxybate, modafinil, and combination treatment on excessive daytime sleepiness in patients who have narcolepsy with or without cataplexy. Black J; Swick T; Bogan R; Lai C; Carter LP Sleep Med; 2016 Aug; 24():57-62. PubMed ID: 27810187 [TBL] [Abstract][Full Text] [Related]
37. Profile of Solriamfetol in the Management of Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea: Focus on Patient Selection and Perspectives. Abad VC Nat Sci Sleep; 2021; 13():75-91. PubMed ID: 33531850 [TBL] [Abstract][Full Text] [Related]